Douglass Winthrop Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Douglass Winthrop Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$386K	Hold	868	–	–	0.01%	215
2025 Q1	$421K	Sell	868 -50	-5%	-$24.2K	0.01%	206
2024 Q4	$370K	Hold	918	–	–	0.01%	230
2024 Q3	$427K	Sell	918 -24	-3%	-$11.2K	0.01%	213
2024 Q2	$442K	Buy	942 +5	+0.5%	+$2.34K	0.01%	205
2024 Q1	$392K	Hold	937	–	–	0.01%	208
2023 Q4	$381K	Hold	937	–	–	0.01%	196
2023 Q3	$326K	Buy	937 +19	+2%	+$6.61K	0.01%	195
2023 Q2	$323K	Hold	918	–	–	0.01%	202
2023 Q1	$289K	Hold	918	–	–	0.01%	207
2022 Q4	$265K	Hold	918	–	–	0.01%	215
2022 Q3	$266K	Hold	918	–	–	0.01%	210
2022 Q2	$259K	Hold	918	–	–	0.01%	223
2022 Q1	$240K	Hold	918	–	–	0.01%	242
2021 Q4	$202K	Buy	+918	New	+$202K	﹤0.01%	266
2021 Q1	–	Sell	-954	Closed	-$225K	–	276
2020 Q4	$225K	Sell	954 -215	-18%	-$50.7K	0.01%	247
2020 Q3	$318K	Sell	1,169 -200	-15%	-$54.4K	0.01%	217
2020 Q2	$397K	Sell	1,369 -74	-5%	-$21.5K	0.01%	187
2020 Q1	$343K	Sell	1,443 -101	-7%	-$24K	0.02%	188
2019 Q4	$338K	Hold	1,544	–	–	0.01%	225
2019 Q3	$262K	Hold	1,544	–	–	0.01%	230
2019 Q2	$283K	Hold	1,544	–	–	0.01%	228
2019 Q1	$284K	Hold	1,544	–	–	0.01%	211
2018 Q4	$256K	Sell	1,544 -106	-6%	-$17.6K	0.01%	217
2018 Q3	$318K	Sell	1,650 -200	-11%	-$38.5K	0.01%	211
2018 Q2	$314K	Sell	1,850 -265	-13%	-$45K	0.01%	234
2018 Q1	$345K	Sell	2,115 -9	-0.4%	-$1.47K	0.02%	220
2017 Q4	$318K	Hold	2,124	–	–	0.02%	201
2017 Q3	$323K	Buy	2,124 +24	+1%	+$3.65K	0.02%	196
2017 Q2	$271K	Buy	+2,100	New	+$271K	0.02%	219
2016 Q4	–	Sell	-3,000	Closed	-$262K	–	246
2016 Q3	$262K	Buy	3,000 +500	+20%	+$43.7K	0.02%	214
2016 Q2	$215K	Buy	+2,500	New	+$215K	0.02%	227
2016 Q1	–	Sell	-2,500	Closed	-$315K	–	239
2015 Q4	$315K	Hold	2,500	–	–	0.02%	187
2015 Q3	$260K	Hold	2,500	–	–	0.02%	207
2015 Q2	$295K	Hold	2,500	–	–	0.02%	207
2015 Q1	$295K	Buy	+2,500	New	+$295K	0.02%	207